Package 60219-1722-6

{"route": ["ORAL"], "spl_id": "d93c4af1-6f7d-4744-8b1e-21d89a5f5c9b", "openfda": {"nui": ["N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000185504", "N0000182140", "N0000185503"], "upc": ["0360219172074"], "unii": ["0C50HW4FO1"], "rxcui": ["754761", "1052658", "1250721"], "spl_set_id": ["4e009f19-4609-4020-bee1-dc27c504046c"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE, PLASTIC (60219-1722-6)", "package_ndc": "60219-1722-6", "marketing_start_date": "20210614"}], "brand_name": "etravirine", "product_id": "60219-1722_d93c4af1-6f7d-4744-8b1e-21d89a5f5c9b", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "60219-1722", "generic_name": "etravirine", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "etravirine", "active_ingredients": [{"name": "ETRAVIRINE", "strength": "200 mg/1"}], "application_number": "ANDA214196", "marketing_category": "ANDA", "marketing_start_date": "20210614", "listing_expiration_date": "20261231"}